Wedbush on Sionna Therapeutics (SION): 'We continue to hold a positive bias'
Tweet Send to a Friend
Wedbush analyst Laura Chico reiterated an Outperform rating and $53.00 price target on Sionna Therapeutics (NASDAQ: SION).The analyst comments "Remain ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
